跳至主要内容
临床试验/NCT07648160
NCT07648160招募中不适用

Contrast-enhanced CBCT With C-arm HyperSight Technology: A Feasibility Study

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2026年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Feasibility of IV-contrast enhanced CBCT during image-guided radiotherapy

研究概览

简要总结

This is a single-arm prospective, feasibility study evaluating the intravenous contrast-enhanced cone beam computed tomography (IV CBCT) for image guidance during radiotherapy. Patients treated with SFRT will receive IV-contrast enhanced CT and fMRI before treatment for simulation purposes. Additionally, patients will receive mpMRI just before and IV-contrast enhanced CBCT during their second and last fraction of RT, in addition to the standard of care CBCT that is acquired for daily image-guided patient positioning. Patients will undergo both IV-contrast enhanced CBCT and treatment on the TrueBeam with HyperSight imaging capability. We hypothesize IV contrast enhanced CBCT is feasible, well-tolerated by patients and improves the visibility of the target.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary biopsy-proven cancer
  • Planning to undergo spatially fractionated radiation therapy
  • Able to provide informed consent
  • Willingness to participate in follow-up
  • ECOG less than or equal to 3
  • Normal creatinine (below 109mmol/L), normal eGF

排除标准

  • Unable to understand/provide consent
  • History of allergic reaction to iodinated IV contrast dye (allergy to MR contrast is not an exclusion criteria)
  • Known renal disease
  • Single kidney
  • Kidney transplant
  • Contraindication to MRI

结局指标

主要结局

Feasibility of IV-contrast enhanced CBCT during image-guided radiotherapy

时间窗: 18 Months

Feasibility of IV-contrast enhanced CBCT in visualizing tumors, vascular structures and tumour micro-environment changes during image-guided radiotherapy. The contrast-to-noise ratio, measuring the ability of an imaging modality to differentiate between various contrasts against the background noise, will be calculated and compared between CT and CBCT, and between with and without contrast acquisition.

次要结局

  • Feasibility of dynamic-contrast-enhanced (DCE) imaging(18 Months)
  • Image quality of full versus half (17 s) CBCT acquisition, with and without contrast enhancement(18 Months)
  • Patient preferences and comfort with the use of IV CBCT during treatment(18 Months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验